Do we have a novel treatment approach to avoid re-thoracotomies?
- Cardiac Surgery
INTERNATIONAL EXPERTS MEETING
Optimizing patient management with CytoSorb Hemoperfusion Therapy in Cardiac Surgery – Scientific evidence and clinical practice
Reduce bleeding complications in Ticagrelor and Rivaroxaban treated patients undergoing emergency Cardiac Surgery
Chair: Prof. Michael Schmoeckel, Hamburg/Germany
Do we have a novel treatment approach to avoid re-thoracotomies?
Dr. Nikola Bradic, Zagreb/Croatia
Share
|
Do we have a novel treatment approach to avoid re-thoracotomies?
- February 2, 2021
- Cardiac Surgery
Share
|
INTERNATIONAL EXPERTS MEETING
Optimizing patient management with CytoSorb Hemoperfusion Therapy in Cardiac Surgery – Scientific evidence and clinical practice
Reduce bleeding complications in Ticagrelor and Rivaroxaban treated patients undergoing emergency Cardiac Surgery
Chair: Prof. Michael Schmoeckel, Hamburg/Germany
Do we have a novel treatment approach to avoid re-thoracotomies?
Dr. Nikola Bradic, Zagreb/Croatia
More Videos
